Ex Parte Adkins et alDownload PDFPatent Trial and Appeal BoardFeb 22, 201712317563 (P.T.A.B. Feb. 22, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 12/317,563 12/23/2008 Rick L. Adkins P09118/MD06-68 4778 157 7590 Covestro LLC 1 Covestro Circle PITTSBURGH, PA 15205 EXAMINER PEPITONE, MICHAEL F ART UNIT PAPER NUMBER 1767 NOTIFICATION DATE DELIVERY MODE 02/24/2017 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): veronica.thompson@covestro.com US-IPR@covestro.com laura.finnell @ covestro. com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte RICK L. ADKINS, STANLEY L. HAGER, BRIAN L. NEAL, JACK R. REESE, JIONG ENGLAND, and MICAH N. MOORE Appeal 2015-006591 Application 12/317,563 Technology Center 1700 Before PETER F. KRATZ, KAREN M. HASTINGS, and MICHAEL P. COLAIANNI, Administrative Patent Judges. HASTINGS, Administrative Patent Judge. DECISION ON APPEAL Appellants1 seek our review under 35 U.S.C. § 134 of the Examiner’ final decision rejecting claims 1, 3, 6—13, 15, and 18—25, 27, 29-32 under pre-AIA 35 U.S.C. § 102(b) as anticipated by Hager (U.S. 2007/0282029 Al, published Dec. 6, 2007, now U.S. Patent 7,456,229 B2 issued Nov. 25 2008), and claims 2, 14, 26, and 28 under 35 U.S.C. § 103(a) as being unpatentable over Hager. We have jurisdiction over the appeal under 35 U.S.C. § 6(b). 1 The Real Party in Interest is stated to be Bayer MaterialScience LLC (App. Br. 1). Appeal 2015-006591 Application 12/317,563 We AFFIRM. Claim 1 is representative of the claimed invention (emphasis added)2: 1. A polymer polyol comprising the free-radical polymerization reaction product of: (1) a base polyol selected from the group consisting of: (c) one or more polyols which comprise the alkoxylation product of one or more natural oils which naturally contains at least one hydroxyl group with one or more alkylene oxides, (d) one or more polyols which comprise the alkoxylation product of one or more hydroxylated derivatives of one or more natural oils with one or more alkylene oxides; and (e) mixtures thereof; (2) at least one ethylenically unsaturated monomer, and (3) a preformed stabilizer, in the presence of (4) a free-radical polymerization initiator, and, optionally, (5) a chain transfer agent. At the outset, we note that while the Examiner separately rejected independent product claim 1 and method claim 13 and its dependent claims, the grounds of the rejection, as well as Appellants’ arguments, are virtually the same for both claims 1 and 13 (See Ans.; App. Br., generally). Accordingly, claims 1 and 13 and all their dependent claims, including those separately rejected, stand or fall together. 2 It is noted that subclauses (a) and (b) were removed from the Markush listing in claim 1, clause (1) (as well as claim 13), leaving claim 1 clause (1) with only subclauses (c), (d), and (e). 2 Appeal 2015-006591 Application 12/317,563 ANALYSIS We have reviewed each of Appellants’ arguments for patentability. However, we determine that a preponderance of the evidence supports the Examiner’s finding that the claimed subject matter of representative claim 1 (as well as its corresponding method claim 13) is anticipated within the meaning of § 102 in view of the applied prior art of Hager. Accordingly, we will sustain the Examiner’s rejections for essentially those reasons expressed in the Answer, including the Examiner’s Response to Argument section, and we add the following primarily for emphasis. Appellants and the Examiner dispute whether Hager describes, within the meaning of § 102, an alkoxylation product of one or more natural oils for the base polyol as recited in each independent claim 1 and claim 13. The Examiner’s position is that Hager describes an alkylene oxide adduct of castor oil or soybean oil in light of paragraphs 51 and 52 of Hager when read as a whole, since paragraph 51 states that “[b]y alkoxylation of the starter, a suitable polyether polyol for the base polyol component can be formed” (e.g., Ans. 11, 12). Appellants’ argument that Hager does not explicitly state alkylene oxide adducts of castor oil in paragraph 52 (App. Br. 5, 6; Reply Br. 2) is not persuasive of reversible error in the Examiner’s anticipation rejection. Rather, a preponderance of the evidence supports the Examiner’s position that one of ordinary skill in the art would have readily recognized/inferred that alkoxylation products (e.g., alkylene oxide adducts) of natural oils (e.g., soybean oil or castor oil as a starter) were specifically included as being among the suitable base polyols described/listed by Hager (Ans. 11, 12; Hager H 51, 52). In rePreda, 401 F.2d 825, 826 (CCPA 1968) (In determining whether a reference anticipates the subject matter 3 Appeal 2015-006591 Application 12/317,563 recited in a claim, “it is proper to take into account not only specific teachings of the reference but also the inferences which one skilled in the art would reasonably be expected to draw therefrom.”) Cf. In re Schaumann, 572 F.2d 312, 317 (CCPA 1978) (In order to anticipate, a reference must identify something falling within the claimed subject matter with sufficient specificity to constitute a description thereof within the purview of § 102.). It is well established that specific examples of the claimed subject matter are not necessary to establish anticipation. Rather, to anticipate, one skilled in the art must be able to “at once envisage” the claimed subject matter in the prior art disclosure. In re Petering, 301 F.2d 676, 681 (CCPA 1962). Thus, a preponderance of the evidence supports the Examiner’s de facto position that one of ordinary skill in the art would have at once envisaged alkylene oxide adducts of natural oils, such as castor and soybean oils, from Hager’s disclosure (Ans. generally). Accordingly, we affirm the Examiner’s anticipation rejection. No further substantive arguments were made regarding the § 103 rejections. Thus, we also affirm the § 103 rejections. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136. ORDER AFFIRMED 4 Copy with citationCopy as parenthetical citation